Onconetix, Inc. (ONCO)
NASDAQ·Healthcare·Biotechnology
$0.77
+2.86%
Mkt Cap $300.80K
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | — | $303.60K | — | — | $12.58 | — | — | — |
| Q4 2025 Nov 13, 2025 | — | $303.65K | — | — | -$6.25 | — | — | — |
| Q3 2025 Aug 14, 2025 | — | $106.49K | — | — | -$4.05 | — | — | — |
| Q2 2025 Jun 12, 2025 | — | $101.63K | — | — | $21.19 | — | — | — |
| Q2 2025 Jun 2, 2025 | — | $711.98K | — | — | -$6.40 | — | — | — |
| Q2 2025 Apr 10, 2025 | — | $711.98K | — | — | -$212.88 | — | — | — |
| Q4 2024 Dec 9, 2024 | — | $406.86K | — | — | -$189.83 | — | — | — |
| Q3 2024 Aug 29, 2024 | — | $704.85K | — | — | -$779.66 | — | — | — |
| Q2 2024 Apr 11, 2024 | — | $58.47K | — | -$714.00 | -$3404.03 | -376.75% | — | — |
| Q4 2023 Oct 20, 2023 | $58.00K | — | — | -$714.00 | -$0.27 | +99.96% | — | — |
| Q2 2023 Jun 30, 2023 | — | — | — | — | -$1467.57 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | -$697.00 | -$608.39 | +12.71% | — | — |
| Q4 2022 Dec 31, 2022 | — | — | — | -$10.60 | -$716.85 | -6662.71% | — | — |
| Q3 2022 Sep 30, 2022 | — | — | — | — | -$916.92 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | — | — | — | -$1208.78 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$1110.87 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$370.38 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$337.31 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$346.14 | — | — | — |